FR2160957A1 - - Google Patents

Info

Publication number
FR2160957A1
FR2160957A1 FR7241464A FR7241464A FR2160957A1 FR 2160957 A1 FR2160957 A1 FR 2160957A1 FR 7241464 A FR7241464 A FR 7241464A FR 7241464 A FR7241464 A FR 7241464A FR 2160957 A1 FR2160957 A1 FR 2160957A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR7241464A
Other languages
French (fr)
Other versions
FR2160957B1 (de
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of FR2160957A1 publication Critical patent/FR2160957A1/fr
Application granted granted Critical
Publication of FR2160957B1 publication Critical patent/FR2160957B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
    • C07D489/08—Oxygen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FR7241464A 1971-11-26 1972-11-22 Expired FR2160957B1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US00202575A US3814768A (en) 1971-11-26 1971-11-26 6-methylene-6-desoxy dihydro morphine and codeine derivatives and pharmaceutically acceptable salts

Publications (2)

Publication Number Publication Date
FR2160957A1 true FR2160957A1 (de) 1973-07-06
FR2160957B1 FR2160957B1 (de) 1975-11-28

Family

ID=22750450

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7241464A Expired FR2160957B1 (de) 1971-11-26 1972-11-22

Country Status (7)

Country Link
US (1) US3814768A (de)
JP (1) JPS5653556B2 (de)
CA (1) CA974235A (de)
CH (1) CH578568A5 (de)
DE (1) DE2257715C2 (de)
FR (1) FR2160957B1 (de)
GB (1) GB1411129A (de)

Cited By (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0107855A1 (de) * 1982-10-28 1984-05-09 E.I. Du Pont De Nemours And Company Verfahren zur Steuerung und Verminderung von Appetit
WO1987001282A2 (en) * 1985-09-06 1987-03-12 Key Pharmaceuticals, Inc. Method and composition for providing sustained opioid antagonism

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322426A (en) * 1980-04-28 1982-03-30 E. I. Du Pont De Nemours And Company 17-Substituted-6-desoxy-7,8-dihydro-6α-methylnoroxymorphone narcotic antagonists
JPS5855258A (ja) * 1981-09-30 1983-04-01 Ricoh Co Ltd 熱転写型カラープリンタ
JPS5889377A (ja) * 1981-11-20 1983-05-27 Canon Inc ドツトプリンタ
US4478840A (en) * 1983-10-11 1984-10-23 E. I. Du Pont De Nemours And Company Appetite suppressing compositions and methods
US4535157A (en) * 1983-11-01 1985-08-13 Key Pharmaceuticals, Inc. Process for making 6-desoxy-6-methylenenaloxone and 6-desoxy-6-methylenenaltrexone
US4639455A (en) * 1984-10-02 1987-01-27 Key Pharmaceuticals, Inc. Means of aiding in the prevention of sudden infant death syndrome
US4751307A (en) * 1985-01-17 1988-06-14 Mallinckrodt, Inc. Wittig-reaction processes
US5028612A (en) * 1990-03-22 1991-07-02 Hillel Glover Method for treating emotional numbness
EP2561860B1 (de) * 2002-05-31 2018-02-28 Titan Pharmaceuticals, Inc. Implantierbare polymere Vorrichtung zur verzögerten Freisetzung von Buprenorphin
MXPA05010450A (es) * 2003-03-31 2005-11-04 Titan Pharmaceuticals Inc Dispositivo polimerico implantable para la liberacion prolongada de agonistas de dopamina.
EP2317316A3 (de) * 2005-07-08 2011-06-15 Braincells, Inc. Verfahren zur Identifizierung von neurogenesemodulierenden Wirkstoffen und Bedingungen
CN103012416B (zh) * 2011-09-28 2015-07-01 辽宁海思科制药有限公司 一种盐酸纳美芬的制备方法
TWI560170B (en) 2011-12-06 2016-12-01 Lundbeck & Co As H Process for recovery of nalmefene hydrochloride
CN102584840A (zh) * 2011-12-28 2012-07-18 南京优科生物医药有限公司 一种制备纳美芬化合物的方法
US20140005216A1 (en) 2012-06-27 2014-01-02 H. Lundbeck A/S Nalmefene for reduction of alcohol consumption in specific target populations
HU231191B1 (hu) 2013-04-15 2021-08-30 Szegedi Tudományegyetem Izotóp tartalmú morfin molekulák
CN103204859B (zh) * 2013-04-25 2015-12-02 四川海思科制药有限公司 一种盐酸纳美芬化合物及其制备方法
TW201625252A (zh) 2014-04-22 2016-07-16 大塚製藥股份有限公司 藥物

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3162639A (en) * 1964-12-22 G-desoxy-ix-hydroxy-dihydromorphine

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0107855A1 (de) * 1982-10-28 1984-05-09 E.I. Du Pont De Nemours And Company Verfahren zur Steuerung und Verminderung von Appetit
WO1987001282A2 (en) * 1985-09-06 1987-03-12 Key Pharmaceuticals, Inc. Method and composition for providing sustained opioid antagonism
WO1987001282A3 (en) * 1985-09-06 1987-08-13 Key Pharma Method and composition for providing sustained opioid antagonism

Also Published As

Publication number Publication date
JPS5653556B2 (de) 1981-12-19
DE2257715C2 (de) 1985-06-05
FR2160957B1 (de) 1975-11-28
DE2257715A1 (de) 1973-05-30
US3814768A (en) 1974-06-04
CA974235A (en) 1975-09-09
GB1411129A (en) 1975-10-22
CH578568A5 (de) 1976-08-13
JPS4858000A (de) 1973-08-14

Similar Documents

Publication Publication Date Title
FR2160957B1 (de)
ATA136472A (de)
AR196074A1 (de)
AU2894671A (de)
AU2941471A (de)
AU2952271A (de)
AU3005371A (de)
AU2415871A (de)
AU2907471A (de)
AR202997Q (de)
AU2755871A (de)
AR199640Q (de)
AU2473671A (de)
AU2456871A (de)
AU1109576A (de)
AU2875571A (de)
AU2880771A (de)
AU2885171A (de)
AU2837671A (de)
AU2455871A (de)
AU2927871A (de)
AU2930871A (de)
AU2938071A (de)
AU2854371A (de)
AU3038671A (de)

Legal Events

Date Code Title Description
TP Transmission of property
TP Transmission of property
TP Transmission of property